Biopharmaceutical wholesalers in Japan play broader roles than their counterparts overseas. Beyond logistics and distribution, wholesalers perform a variety of tasks related to finance, safety, and commercialization. Such functions are typically cited as justification for various fees, rebates, and allowances…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Japan Drug Makers Derive Near-60% of FY2020 Sales Overseas as Home Market Falters: Tally
June 8, 2021
-
BUSINESS FDA Approves Aducanumab, 1st Disease-Modifying Therapy for Alzheimer’s
June 8, 2021
-
BUSINESS Bristol Myers, Other Pharma Players Moving to Join Workplace Vaccination Campaign
June 7, 2021
-
BUSINESS Kobayashi Kako’s 116-Day Suspension Over, but No Timeline for Resumption
June 7, 2021
-
ACADEMIA As Aducanumab Decision Nears, Health Economist Stresses Need for Broad Value Evaluation, Target Patient Criteria
June 4, 2021
-
BUSINESS MSD Japan Spins Off Organon Women’s Health Biz, Ryota Sakurai Takes Helm
June 4, 2021
-
BUSINESS Astellas Plans to Cut 450 Jobs via Voluntary Redundancy Program
June 4, 2021
-
REGULATORY Japan to Establish Ecosystem to Deliver Innovative Drugs: Draft Growth Strategy
June 3, 2021
-
BUSINESS Keio Upstart, Novo Nordisk Ink Global Deal on iPSC-Based Heart Therapy
June 2, 2021
-
REGULATORY Blue Letter Issued to OA Drug Joyclu after Anaphylaxis Reports
June 2, 2021
-
BUSINESS SGLT2 Inhibitors Again Poised for Double-Digit Growth in FY2021; Forxiga Overtakes Jardiance in April
June 1, 2021
-
COMMENTARY Battle Looming over 2% Adjustment Rate as New Honebuto Paper Nears Completion
June 1, 2021
-
BUSINESS Ayumi Curbs Enbrel Biosimilar Shipments in Fallout from Indian API Supply Disruption
June 1, 2021
-
BUSINESS Pfizer Vaccine Now OK’ed for Adolescents, 1-Month Storage in Refrigerators
June 1, 2021
-
ORGANIZATION Experts Eye Macroeconomic Indexing of Drug Costs to Keep Innovation Afloat: INES Proposal
May 31, 2021
-
BUSINESS Yoshindo/Teijin Halt Enbrel Shipments as COVID-19 Stalls Indian API Supplies
May 31, 2021
-
REGULATORY Panel OK’s Pfizer Vaccine Use in Age 12-Plus, Longer Refrigerator Storage
May 31, 2021
-
ACADEMIA Hematologist Sees No Swelling Costs from 2 New CAR-T Contenders in Japan; Will Competition Drive Down Prices?
May 28, 2021
-
REGULATORY Japan Approves Rinvoq for Psoriasis, More Drugs for Label Expansions
May 28, 2021
-
BUSINESS Takeda Stepping Up Work to Improve Japanese Ecosystem for Rare Diseases
May 27, 2021
ページ
With its first “off-year” drug price revision implemented this April, Japan has now wrapped up all the reform plans agreed upon by four state ministers in 2016 for pharmaceutical pricing. As the government has provided no further mid-term vision for…
The average ratio of female employees at managerial posts stood at just 12.5% at pharmaceutical companies operating in Japan, a Jiho survey revealed. While foreign drug makers had an average 25.0%, the ratio came to as low as 9.8% for…
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…